These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21544607)

  • 1. Production of phloroglucinol by Escherichia coli using a stationary-phase promoter.
    Cao Y; Xian M
    Biotechnol Lett; 2011 Sep; 33(9):1853-8. PubMed ID: 21544607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved phloroglucinol production by metabolically engineered Escherichia coli.
    Cao Y; Jiang X; Zhang R; Xian M
    Appl Microbiol Biotechnol; 2011 Sep; 91(6):1545-52. PubMed ID: 21643705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic engineering of Escherichia coli for the production of fumaric acid.
    Song CW; Kim DI; Choi S; Jang JW; Lee SY
    Biotechnol Bioeng; 2013 Jul; 110(7):2025-34. PubMed ID: 23436277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving phloroglucinol tolerance and production in Escherichia coli by GroESL overexpression.
    Zhang R; Cao Y; Liu W; Xian M; Liu H
    Microb Cell Fact; 2017 Dec; 16(1):227. PubMed ID: 29258595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directed evolution of phloroglucinol synthase PhlD with increased stability for phloroglucinol production.
    Rao G; Lee JK; Zhao H
    Appl Microbiol Biotechnol; 2013 Jul; 97(13):5861-7. PubMed ID: 23358999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of phloroglucinol.
    Achkar J; Xian M; Zhao H; Frost JW
    J Am Chem Soc; 2005 Apr; 127(15):5332-3. PubMed ID: 15826166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phloroglucinol mediates cross-talk between the pyoluteorin and 2,4-diacetylphloroglucinol biosynthetic pathways in Pseudomonas fluorescens Pf-5.
    Kidarsa TA; Goebel NC; Zabriskie TM; Loper JE
    Mol Microbiol; 2011 Jul; 81(2):395-414. PubMed ID: 21564338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kil gene of the ColE1 plasmid of Escherichia coli controlled by a growth-phase-dependent promoter mediates the secretion of a heterologous periplasmic protein during the stationary phase.
    Miksch G; Fiedler E; Dobrowolski P; Friehs K
    Arch Microbiol; 1997; 167(2-3):143-50. PubMed ID: 9133321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of enantiopure (S)-3-hydroxybutyric acid in metabolically engineered Escherichia coli.
    Lee SH; Park SJ; Lee SY; Hong SH
    Appl Microbiol Biotechnol; 2008 Jun; 79(4):633-41. PubMed ID: 18461320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial expression system with tightly regulated gene expression and plasmid copy number.
    Bowers LM; Lapoint K; Anthony L; Pluciennik A; Filutowicz M
    Gene; 2004 Sep; 340(1):11-8. PubMed ID: 15556290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of efficient recombinant Escherichia coli strains for the production of 3-hydroxypropionic acid from glycerol.
    Rathnasingh C; Raj SM; Jo JE; Park S
    Biotechnol Bioeng; 2009 Nov; 104(4):729-39. PubMed ID: 19575416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of phloroglucinol compounds in microorganisms--review.
    Yang F; Cao Y
    Appl Microbiol Biotechnol; 2012 Jan; 93(2):487-95. PubMed ID: 22101786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.
    Ying H; Tao S; Wang J; Ma W; Chen K; Wang X; Ouyang P
    Microb Cell Fact; 2017 Mar; 16(1):52. PubMed ID: 28347340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic engineering for acetate control in large scale fermentation.
    Tao Y; Cheng Q; Kopatsis AD
    Methods Mol Biol; 2012; 834():283-303. PubMed ID: 22144366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an oxygen-dependent inducible promoter, the Escherichia coli nar promoter, in gram-negative host strains.
    Lee KH; Cho MH; Chung T; Chang HN; Lim SH; Lee J
    Biotechnol Bioeng; 2003 May; 82(3):271-7. PubMed ID: 12599253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High isoprenoid flux Escherichia coli as a host for carotenoids production.
    Suh W
    Methods Mol Biol; 2012; 834():49-62. PubMed ID: 22144352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems metabolic engineering of Escherichia coli for gram scale production of the antitumor drug deoxyviolacein from glycerol.
    Rodrigues AL; Becker J; de Souza Lima AO; Porto LM; Wittmann C
    Biotechnol Bioeng; 2014 Nov; 111(11):2280-9. PubMed ID: 24889673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic engineering of Pseudomonas fluorescens for the production of vanillin from ferulic acid.
    Di Gioia D; Luziatelli F; Negroni A; Ficca AG; Fava F; Ruzzi M
    J Biotechnol; 2011 Dec; 156(4):309-16. PubMed ID: 21875627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escherichia coli W as a new platform strain for the enhanced production of L-valine by systems metabolic engineering.
    Park JH; Jang YS; Lee JW; Lee SY
    Biotechnol Bioeng; 2011 May; 108(5):1140-7. PubMed ID: 21191998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New alkane-responsive expression vectors for Escherichia coli and pseudomonas.
    Smits TH; Seeger MA; Witholt B; van Beilen JB
    Plasmid; 2001 Jul; 46(1):16-24. PubMed ID: 11535032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.